Public disclosures

XGN insider disclosures

Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.

Advertisement
More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSourceFollow
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 2529436 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $4.05 to $4.31, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-132026-11-13

≈ $236,917.44

58,068 shares/units

SEC 4Follow
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 2587504 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $4.52 to $4.95, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The filing of this Form 4 constitutes an exit filing for the Reporting Person.

2026-11-122026-11-13

≈ $508,877.40

109,436 shares/units

SEC 4Follow
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 2696940 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $4.82 to $5.42, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

2026-11-112026-11-12

≈ $372,977.45

71,315 shares/units

SEC 4Follow
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 2625625 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

2026-11-102026-11-10

≈ $37,267.10

7,085 shares/units

SEC 4Follow
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 2618540 · SEC code covers open-market or private transactions · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.26 to $7.00, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

2026-11-092026-11-10

≈ $53,975.00

8,500 shares/units

SEC 4Follow
Chernett Jorey

10% owner · EXAGEN INC.

XGN

EXAGEN INC.

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 2610040 · SEC code covers open-market or private transactions · The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $5.86 to $6.18, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold. · The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer. · This amount corrects a clerical error in the Reporting Person's previously filed Form 4 in which the number of shares beneficially owned by the Reporting Person was under-reported by 2,765 shares.

2026-11-062026-11-10

≈ $69,167.10

11,265 shares/units

SEC 4Follow
Nova Tina Susan

Director · EXAGEN INC.

XGN

EXAGEN INC.

Equity grant or award
Filing details

SEC transaction code A

Stock Option(right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 137313 · The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

2026-06-092026-11-02

56,200 shares/units

SEC 4Follow

Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.

Advertisement